S. Matou

发表

AUTOMATIC QUANTIFICATION OF IN VITRO ENDOTHELIAL CELL NETWORKS USING MATHEMATICAL MORPHOLOGY

J. Angulo, S. Matou, 2005 .

Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression.

I. Laurendeau, S. Matou, B. L. Le Bonniec, 2003, Molecular pharmacology.

Low Molecular Weight Fucoidan and Heparin Enhance the Basic Fibroblast Growth Factor-Induced Tube Formation of Endothelial Cells through Heparan Sulfate-Dependent (cid:1) 6 Overexpression

I. Laurendeau, S. Matou, A. Fischer, 2003 .

Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.

D. Letourneur, S. Matou, D Letourneur, 1998, European journal of cell biology.

Effect of an oversulfated exopolysaccharide on angiogenesis induced by fibroblast growth factor-2 or vascular endothelial growth factor in vitro.

S. Matou, A. Fischer, J. Guézennec, 2005, Biochemical pharmacology.

A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis.

S. Matou, P. Mourão, A. Fischer, 2002, Molecular cancer research : MCR.

Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro.

S. Matou, A. Fischer, D. Helley, 2002, Thrombosis research.

Cheiradone: a vascular endothelial cell growth factor receptor antagonist

M. Slevin, J. Gaffney, S. Matou, 2008, BMC Cell Biology.

Fucoidan, as Heparin, Induces Tissue Factor Pathway Inhibitor Release from Cultured Human Endothelial Cells

S. Matou, A. Fischer, J. Giraux, 1998, Thrombosis and Haemostasis.

Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways.

R. Savani, H. DeLisser, J. Krupiński, 2007, Matrix biology : journal of the International Society for Matrix Biology.

Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis

M. Slevin, J. Gaffney, S. Matou, 2008, Angiogenesis.

Monomeric C-reactive protein-a key molecule driving development of Alzheimer’s disease associated with brain ischaemia?

S. Love, L. Badimón, J. Krupiński, 2015, Scientific Reports.

Application of mathematical morphology to the quantification of in vitro endothelial cell organization into tubular-like structures.

J Angulo, J. Angulo, S. Matou, 2007, Cellular and molecular biology.

Modulation of Vascular Human Endothelial and Rat Smooth Muscle Cell Growth by a Fucosylated Chondroitin Sulfate from Echinoderm

D. Letourneur, S. Matou, A. Fischer, 2000, Thrombosis and Haemostasis.

C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression.

L. Badimón, J. Krupiński, M. Slevin, 2008, BMC cell biology.

Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia

L. Tsai, J. Montaner, J. Krupiński, 2013, PloS one.

Cheiradone: a vascular endothelial cell growth factor receptor antagonist.

M. Slevin, J. Gaffney, S. Matou, 2008 .

Cheiradone: a vascular endothelial cell growth factor receptor antagonist

M. Slevin, J. Gaffney, S. Matou, 2008, BMC Cell Biology.

C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression

L. Badimón, J. Krupiński, M. Slevin, 2008, BMC Cell Biology.

Bmc Cell Biology C-reactive Protein Exerts Angiogenic Effects on Vascular Endothelial Cells and Modulates Associated Signalling Pathways and Gene Expression

L. Badimón, J. Krupiński, M. Slevin, 2008 .